The polyomavirus middle tumor antigen (mT) is required for induction of a broad spectrum of tumors in mice and for transformation of rat fibroblasts in culture (15, 35) . mT is a membrane-bound nonenzymatic protein which acts by providing a core for the assembly of a number of cellular factors involved in intracellular signalling. The latter include pp60 c-src (and other members of the Src kinase family), phosphatidylinositol 3-kinase (PI3K), phospholipase C␥, the Shc proteins, members of the 14-3-3 family of proteins, and protein phosphatase 2A (11, 23, 27, 53, 55, 67, 75, 78) . A crucial step in the assembly of mT complexes with some of these factors is the binding and activation of the protein tyrosine kinase pp60 c-src by mT, a step promoted by the action of a serine kinase(s) on mT (46) . Phosphorylation of mT by pp60 c-src on specific tyrosines then generates binding sites for mT-associated proteins. Thus, phosphotyrosine at positions 250, 315, and 322 promote binding to Shc (11, 27) , the p85 regulatory subunit of PI3K (2, 69) , and phospholipase C␥ (67) , respectively.
The binding of these cellular factors to mT results in the generation of multiple intracellular signals that are presumably important for virus growth but which can also lead to neoplastic transformation in nonproductively infected cells. The same cellular factors are involved in a wide variety of signalling processes in normal cells. The Shc family of proteins contain an SH2 domain and bind to activated tyrosine kinase receptors (48, 56) . Tyrosine phosphorylated Shc proteins are thought to be involved in mammalian Ras signalling pathways (47) , serving as adapters to link receptors to Grb2 (62) . Grb2, in turn, has been implicated in the binding of Sos, a Ras GDP/GTP exchange factor (47) . PI3K is a dual-specificity phospholipid, protein (serine) kinase that is widely associated with tyrosine kinase receptors (1, 12, 16) . PI3K has been implicated in vesicular transport (36) , insulin-activated glucose transport (17, 22, 52) , internalization of the platelet-derived growth factor receptor (39) , activation of pp70 S6 kinase (pp70 S6K ) (17, 20, 24, 50, 57) , and other signal transduction pathways (1) . Phospholipase C␥ is the critical enzyme in production of two important second messengers, inositol 1,4,5-triphosphate and diacylglycerol (6) .
While some aspects of the mechanisms involved in the formation of complexes between mT and these signalling molecules are recognized, the downstream effects of the complexes on transformation remain largely unknown. An important challenge at present is to link each of the proximal events of signalling from mT to specific downstream biochemical events and pathways that collectively lead to the emergence of a fully transformed phenotype. The binding of both PI3K and Shc to mT is essential for transformation, as revealed by early work on mT mutants (13, 28, 29, 45) . Mutant 315YF, in which tyrosine 315 is replaced by phenylalanine (originally designated mutant 1178T [13] ), encodes an mT that activates pp60 c-src but fails to bind PI3K (69) . 315YF induces incomplete transformation of rat fibroblasts (13) and is compromised in its ability to induce tumors in mice (34) . Similarly, mT mutants in which tyrosine 250 is replaced by phenylalanine (250YF mutants) fail to bind Shc (11, 27) and are also defective for transformation (28, 29, 45) .
Here we utilize mutants 250YS and 315YF to discriminate between the downstream effects of mT acting through PI3K or Shc at discrete molecular and cell biological levels. Activation of pp70 S6K was chosen as a target for several reasons. Previous work has shown that two mT-dependent mechanisms contribute to increased S6 phosphorylation. One involves activation of an S6 kinase(s) and is dependent on mT activation of pp60 c-src ; the other is independent of mT-pp60 c-src interaction and may reflect negative regulation of an S6 phosphatase (68) . How mT exerts these effects, and specifically whether pp70 S6K is in-volved, is unknown. S6 phosphorylation is principally controlled by pp70 S6K (8, 21) , and the function of this enzyme is essential for serum-induced G 1 progression in rat embryo fibroblasts (42, 60) . Ribosomes that contain phosphorylated S6 selectively translate a family of mRNA transcripts containing a polypyrimidine tract at the 5Ј end (37, 38) . The pathways by which pp70 S6K are regulated are complex and yet to be fully defined (77) , but they are distinct from the well-characterized mitogen-activated protein kinase pathway which functions in the activation of pp90 rsk (7, 66) . Thus, the normal regulation of this enzyme, as well as its role in translational control of cell cycle progression (37, 42, 60) , raises interesting questions in relation to neoplastic transformation. The abilities of the mutants to induce morphological transformation and loss of cell growth control have been studied and compared. Results have shown that pp70 S6K is activated through mT-PI3K interaction alone, that both Shc and PI3K pathways independently give rise to decreased serum dependence of growth but to a lesser extent than with wild-type virus, and that both pathways are essential for induction of anchorage-independent growth.
MATERIALS AND METHODS
Viruses and cells. Polyomavirus stocks were prepared on primary baby mouse kidney cells (73) . Polyomavirus mutants of NG-59 (5) and 1178T (13) have been described previously. Mutant 1178T, in which tyrosine 315 in mT is replaced by phenylalanine, is referred to henceforth as 315YF. Polyomavirus mutant 250YS encodes an mT with serine in place of tyrosine at residue 250. Mutant 250YS was generated by site-directed mutagenesis using the oligomer 5Ј-CCCGACCTCT TCTGTTATG and a single-stranded template from a subclone containing the wild-type viral mT coding sequence from PstI (nucleotide 484) to EcoRI (nucleotide 1560) as previously described (33) . The mutated base is underlined. This mutation does not alter the amino acid sequence in the overlapping large-Tantigen reading frame. The DNA fragment containing the mutation was ligated to the appropriate fragment of the cloned viral genome and transfected into NIH 3T3 cells. The viral lysate was plaque purified and expanded on baby mouse kidney cells.
NIH 3T3 cells were grown at 37ЊC on Dulbecco modified Eagle medium (DMEM) supplemented with 5% calf serum. Nearly confluent monolayers were infected at a multiplicity of 10 to 50 PFU per cell. Following a 90-min adsorption period, the monolayer was washed once with phosphate-buffered saline (PBS), fresh medium containing 0.1% bovine serum albumin (BSA) was added, and cells were incubated for 35 to 40 h.
Rat F111 cell lines PyF-WT, PyF-315YF, and PyF-250YS, stably expressing wild-type, 315YF, or 250YS mT, were generated by infecting F111 cells with the respective polyomaviruses and cloning the resulting foci.
Cell extracts, immunoprecipitations, and immunoblot analysis. Confluent 90-mm-diameter dishes of cells were washed once in STE (150 mM NaCl, 50 mM Tris-HCl [pH 7.2], 1 mM EDTA) and extracted for 20 min at 4ЊC with 0.35 ml of lysis buffer [10 mM potassium phosphate (pH 7.2), 1 mM EDTA, 5 mM ethylene glycol-bis(␤-aminoethyl ether)-N,N,NЈ,NЈ-tetraacetic acid (EGTA), 10 mM MgCl 2 , 50 mM ␤-glycerophosphate, 1 mM Na 3 VO 4 , 2 mM dithiothreitol, 40 g of phenylmethylsulfonyl fluoride per ml, 0.5% Nonidet P-40]. Lysates were cleared at 13,000 ϫ g, heated in sample buffer for 5 min at 95ЊC, and resolved by electrophoresis on a sodium dodecyl sulfate (SDS)-7.5 or 10% polyacrylamide gel (40) . mT and pp70 S6K were detected by enhanced chemiluminescence (ECL; Amersham), using the mouse monoclonal antibody F4, which recognizes the common amino-terminal region of large T antigen, mT, and small T antigen (54), or a rabbit antiserum prepared against pp70 S6K (from J. Blenis, Harvard Medical School). Anti-Shc immunoblots of mT immunoprecipitated with mouse monoclonal antibody PAb762 (27) (from S. Dilworth, Hammersmith Hospital, London, England) were prepared with ECL and a polyclonal rabbit antiserum to Shc (Transduction Laboratories). Anti-p85 immunoblots of mT immunoprecipitated with anti-T ascites fluid (64) were prepared with anti-rat PI3K (Upstate Biotechnology) and 125 I-labeled second antibody. Quantitation of immunoblots was performed with either ECL phosphor imaging analysis or scintillation counting of bands labeled with 125 I-labeled second antibody and found to be linear over a 5-to 10-fold range.
Kinase assays. mT-associated PI3K was assayed in immunoprecipitates made with anti-T ascites fluid as described previously (26) . To measure the effect of wortmannin on PI3K activity in vitro, extracts prepared from wortmannintreated cells were immunoprecipitated with anti-T ascites fluid, washed, and assayed for PI3K activity in the presence of wortmannin at various concentrations. Wortmannin was added to the enzyme assay mixture because PI3K inhibition by wortmannin can be somewhat reversed during the process of immunoprecipitation (52) . pp70 S6K activity was measured essentially as described by Terada et al. (70) Phospholipids were deacylated with 25% methylamine-methanol-nbutanol (4:4:1, by volume) for 50 min at 53ЊC and dried in vacuo. After extraction with n-butanol-petroleum ether-ethyl formate (20:4:1, by volume), the radiolabeled glycerolipids were analyzed by high-pressure liquid chromatography as previously described (3) . Lipid standards were generated in PI3K assays using phosphatidylinositol (PI) and PI 4-phosphate as substrates.
Transformation and plaque assays. Transformation assays on established F111 rat fibroblasts and plaque assays using UC1-B cells have been described previously (30) . To measure anchorage-independent growth of F111 cell lines stably expressing T antigens, cells were seeded in 0.4% agar medium at a density of 10 4 cells per 60-mm-diameter dish. Fifty randomly selected colonies were scored for cell number after 6 days at 37ЊC.
RESULTS

mT-dependent activation of pp70
S6K requires binding of PI3K but not of Shc. By using specifically altered mutants of polyomavirus, it should be possible to discern the individual contributions of discrete signalling pathways involving mT to the overall process of neoplastic transformation at the molecular and cell biological levels. Two mutants previously described were chosen for this study on the basis of their known properties; a third mutant was constructed and analyzed in this study. NG-59, a prototype of the hr-t mutant group altered in both mT and small T antigen, is totally null in all aspects of cell transformation and mT-associated functions (14, 63) . 315YF, a partially transforming mutant, encodes an mT specifically blocked in binding of PI3K but is fully able to activate pp60 c-src (13) . 250YS has an alteration in mT predicted to result in an inability to bind the Shc family of proteins. The point mutations in 350YF and 250YS are both silent in the overlapping reading frame encoding large T antigen. Both large and small T antigens are therefore normal in these mutants. Both mutants can be grown in culture as well, or nearly as well, as wild-type virus.
In cells infected by polyomavirus, induction of S6 kinase activity depends on activation of pp60 c-src by mT (68); thus, either mutant 315YF acting through Shc or mutant 250YS acting through PI3K, or possibly both, might be expected to retain this function. NIH 3T3 cells were infected by wild-type virus or various mutants and were serum starved. Cell extracts were then prepared and used to monitor mT interactions with PI3K and Shc and the level of pp70 S6K activation. By infecting with various dilutions of virus, cells expressing similar levels of mT could be compared (Fig. 1A) . Binding of mT to PI3K was evaluated by in vitro PI3K assays in T-antigen immunoprecipitates, while Shc binding to mT was determined by immunoblot analysis of mT immunoprecipitates. NG-59 fails to bind both PI3K and Shc, as expected for a mutant that fails to associate with pp60 c-src . 315YF binds Shc but not PI3K, and 250YS binds PI3K but not Shc (Fig. 1B and C) . The abilities of mutant and wild-type mTs to promote phosphorylation and activation of pp70 S6K were determined by immunoblot analysis (Fig. 1D ) and direct enzyme assay of anti-pp70 S6K immunoprecipitates ( Fig. 1E) . Maximal or nearly maximal levels of phosphorylation and activation were achieved by adding 10% serum to quiescent cells as a positive control. Infection by wild-type virus and mutant 250YS activated pp70 S6K to levels comparable to that achieved with serum. Phosphorylation which accompanies activation led to a reduced mobility on SDS-polyacrylamide gel electrophoresis of both the 70-kDa ␣II form of pp70 S6K (Fig.  1D ) and the 85-kDa ␣I form (not shown). Mutants NG-59 and 315YF were without effect on phosphorylation and activation of pp70 We have observed that PI3K activity coimmunoprecipitating with 250YS mT is somewhat variable and usually slightly lower than that coimmunoprecipitating with wild-type mT. To further verify the binding of PI3K to 250YS mT, levels of the p85 regulatory subunit of PI3K were measured along with PI3K activity in T-antigen immunoprecipitates prepared from extracts containing equal levels of mT protein. The results in Fig.  2 show that the level of p85 bound to 250YS mT complexes and the amount of associated PI3K activity were between 50 and 70% of those seen in wild-type immunoprecipitates. Similar results have been obtained in several independent experiments. Tyrosine at residue 250 in mT may therefore contribute somewhat to the stability of binding and of PI3K activity in the in vitro assay. The data nevertheless support the conclusion that activation of pp70 S6K by 250YS and wild-type mT correlates with binding of PI3K.
PI3K products in cell lines expressing wild-type and mutant mTs. Although it is generally accepted that in vitro binding of PI3K to activated growth factor receptors or mT correlates with in vivo activation of the enzyme, two exceptions have been reported. mT mutants in which proline 248 is replaced with leucine (248m) or amino acids 338 to 347 are deleted (dl1015) are reported to bind PI3K in vitro but fail to activate the enzyme in vivo (44) . Also, a mutant of the nerve growth factor receptor Trk-A which lacks tyrosine at residue 490, the purported binding site for Shc, fails to activate PI3K both in vitro and in vivo, whereas a Trk-A receptor lacking tyrosine 751, the purported binding site for p85, retains ability to activate PI3K in vitro and in vivo (4) . To confirm that in vitro binding of PI3K to mT correlates with in vivo activation, rat fibroblast cell lines expressing wild-type, 315YF, and 250YS mTs were assessed for steady-state levels of PI 3,4-bisphosphate [PI(3,4)P 2 ]. The data in Fig. 3 show little increase in PI(3,4)P 2 formation in 315YF mT-expressing cells, whereas PI(3,4)P 2 levels were increased threefold in 250YS and wild-type mT-expressing cells. The finding for 315YF supports the report by Ulug et al. (74) that mutant dl23, which also fails to bind and activate PI3K in vitro, shows no increase in levels of 3-phosphorylated inositol lipids in vivo. Although mutants 250YS and 248m have similar in vitro biochemical phenotypes, i.e., both are negative for mTShc binding (Fig. 1) (27) but positive for mT-PI3K binding in vitro ( Fig. 1) (2, 28) , unlike 250YS (discussed below), mutant 248m is completely transformation defective (28) and fails to . Numbers following the virus types indicate viral dilutions used for infections. Data in all panels were from extracts generated in the same experiment. Similar results were found in two separate experiments.
FIG. 2.
Binding of p85 and PI3K to 250YS mT. Extracts containing equal levels of mT were prepared from NIH 3T3 cells infected as described in the legend to Fig. 1 . p85 immunoprecipitating with mT was subjected to immunoblot analysis using an anti-PI3K antibody (Upstate Biotechnology) and 125 I-labeled second antibody. Labeled bands were excised and quantitated by liquid scintillation counting. PI3K activity in T-antigen immunoprecipitates was assayed as described in Materials and Methods and quantitated by phosphor imaging analysis. The data were from duplicate determinations. WT, wild type. (58, 71) , although it may have additional effects (25) . To support the finding that PI3K is on the pathway of mT-dependent pp70 S6K activation, further evidence was sought by using wortmannin as a PI3K inhibitor. Serum-starved NIH 3T3 cells infected with wild-type or mutant 250YS virus were treated for 1 h prior to lysis with increasing concentrations of wortmannin. In cells expressing equivalent levels of mT (Fig. 4A) , the in vivo inhibitory concentration curves for pp70 S6K phosphorylation (Fig.  4B) and activation (Fig. 4C ) and for PI3K in vitro (Fig. 4D) were similar for both wild-type-and 250YS-infected cells. These results support the involvement of PI3K in mT-dependent activation of pp70 S6K . Polyomavirus mutants 315YF and 250YS induce partial and phenotypically distinct forms of transformation. Neoplastic transformation of cells in culture has been assessed by different parameters, including morphological changes, growth as foci on normal cell monolayers, and anchorage-independent growth. In F111 rat fibroblasts, these phenotypic changes show graded responses to increasing levels of mT expression, with morphological changes requiring the lowest levels and anchorage-independent growth requiring the highest levels (59) . To analyze the contributions of the mT-Shc and mT-PI3K pathways to various parameters of transformation, mutants 250YS and 315YF were used along with wild-type virus to infect F111 cells. 315YF and 250YS induced weak foci with distinct focal morphologies that made them readily distinguishable from each other as well as from wild-type foci (Fig. 5) . Cells comprising foci induced by 315YF were of normal size, fusiform, loosely packed, and moderately adherent to the plastic substratum (Fig. 5C) . Cells transformed by 250YS appeared to be smaller and more polygonal, closely packed, and tightly adherent to the dish (Fig. 5D) . By comparison, cells comprising wild-type foci tended to be more round and refractile in appearance, densely packed, and weakly adherent (Fig. 5B) .
The efficiencies of transformation (transforming units per PFU) were compared by focus formation and by growth in soft agar. Scored by focus-forming ability, the mutants were lower by a factor of 10 to 30 compared with the wild type and by 1,000-fold or more when compared by induction of growth in soft agar (Table 1) . These results show that signalling through either PI3K or Shc alone can give rise to morphological transformation, but with reduced efficiency and notable qualitative differences from wild-type virus, and that neither pathway by itself is sufficient for induction of anchorage-independent growth.
Serum and anchorage dependence of growth in cells stably transformed by mutants 250YS and 315YF. F111 cells stably expressing 250YS or 315YF mutant mT were cloned from primary foci, confirmed by immunoblotting to express comparable levels of mT, and tested for their abilities to grow in low Fig. 6 show that at the lowest concentration of serum, the mutant mT lines grew substantially better than normal F111 cells, though not quite as well as the clones expressing wild-type mT. At higher concentrations, the mutant lines remained intermediate between untransformed and wild-type-transformed cells, but the relative differences were less. When the cells were suspended in soft nutrient agar and examined for distribution of clone size after 6 days, it was evident that only the wild-type-transformed cells grew efficiently, giving rise to macroscopically visible colonies (approximately 20 cells or more). While neither of the mutant lines grew as well as the wild type, 315YF cells grew detectably better than 250YS cells, as determined by microscopic counts (Fig. 7) . These results show that while both Shc and PI3K pathways are needed for efficient anchorage-independent growth, either pathway alone can promote substantial growth in low concentrations of serum. It should be noted that a mutant polyomavirus which fails to express mT but encodes normal small and large T antigens is ineffective in inducing anchorage-independent growth but can promote some growth in low serum (43) . Since mutants 250YS and 315YS express normal small and large T antigens, these proteins most likely contribute to the levels of growth in low serum observed in the mT mutant lines (Fig. 6 ).
DISCUSSION
This study extends an earlier report on polyomavirus-induced elevation of ribosomal protein S6 phosphorylation (68) by demonstrating activation of pp70 S6K in a pathway mediated by mT and PI3K. Genetic and biochemical evidence supports the conclusion that PI3K binding to mT is required for activation of both the cytoplasmic (70-kDa) and nuclear (85-kDa) forms of S6 kinase. Polyomavirus mutant 315YF, which is specifically defective in PI3K binding (69) and activation, fails to activate pp70 S6K despite activating pp60 c-src normally. Wortmannin at concentrations of Ͻ100 nM effectively blocks pp70 S6K activation in wild-type virus-infected cells in parallel with inhibiting mT-associated PI3K activity. mT thus acts similarly to a variety of stimuli in linking activated tyrosine kinases to pp70 S6K through PI3K (17, 19, 20, 24, 50, 57) . The results further indicate that binding of the Shc proteins, purportedly involved in a signalling network leading to Ras (47) , is neither necessary nor sufficient for mT activation of pp70 S6K . This is indicated by the ability of mutant 250YS, which fails to bind Shc, to fully activate pp70 S6K and by the inability of mutant 315YF to stimulate pp70 S6K activity despite binding Shc normally. Although 250YS mT binds PI3K in vitro slightly less well than wild-type mT, 250YS activates PI3K in vivo to wild-type levels. Elevation in levels of S6 phosphorylation is also found in v-ras-transformed cells (9) , but it is not . In human 293 cells, activation of pp70 S6K occurs by a pathway independent of p21 ras (49) . Activation of pp70 S6K shows the same dependence on mT functions as does the elevation of glucose transport, which also requires interaction with PI3K and not with Shc (79) . Although these results are consistent with the notion that Shc and PI3K binding to mT trigger separate parallel biochemical pathways, downstream interactions are expected to occur. Cross talk between Ras or Raf and PI3K has in fact been found in several systems (24, 61, 65) .
The mechanism by which mT binding of PI3K leads to phosphorylation and activation of pp70 S6K remains unknown, as does the identification of the possible PI3K products involved. Phosphorylation of pp70 S6K at multiple sites both outside and within an autoinhibitory pseudosubstrate domain activates the enzyme, although the relevant kinases have not been defined (18, 76, 77) . The protein serine kinase activity of PI3K is blocked by wortmannin (41) , raising the possibility that PI3K phosphorylates pp70 S6K directly. However, a recent study showing that a fragment of p70 S6K is not a substrate for PI3K in vitro rules against this possibility (76) . Other possible downstream targets of PI3K in pp70 S6K regulation are members of the calcium-insensitive protein kinase C family (51, 72) and the recently identified serine/threonine protein kinase B/Akt (10, 31) .
At the cellular level, the mT-PI3K and mT-Shc pathways act independently of one another to effect some parameters of transformation but must act synergistically to elicit others. In established rat embryo fibroblasts, each pathway by itself induces a characteristic type of morphological transformation which appears weak or incomplete compared with that induced by wild-type mT. Each of the pathways also leads to decreased serum dependence of growth, and their effects may be additive in reaching the level of serum independence achieved by wildtype mT. With respect to induction of anchorage-independent growth, interactions of mT with both Shc and PI3K are required, and the effects of the two pathways are clearly synergistic rather than additive. This result indicates a requirement for downstream integration of signals from both pathways for induction of anchorage-independent growth.
Activation of pp70
S6K through the mT-PI3K pathway most likely plays a role in the emergence of at least some transformation-related changes, given the known role of S6 kinase in normal mitogenesis (42, 60) . The mutant 315YF, defective in the mT-PI3K pathway, stimulates growth of cells in low serum and, to a limited extent, in soft agar. While these effects of the mutant are most likely mediated primarily through the mT-Shc pathway, phosphorylation of S6 may still play a role since this mutant elevates S6 phosphorylation through some kinase-independent mechanism (68) .
The partially transforming virus mutants 315YF and 250YS are both able to induce tumors upon inoculation of newborn mice, but with reduced efficiency, altered time course, and some changes in the spectrum and histological features of the tumors compared with wild-type virus (32, 34) . Further studies FIG. 6 . Effects of serum concentration on cell yields of F111-derived cell lines containing wild-type or mutant mT. Cell lines F111, PyF-250YS, PyF-315YF, and PyF-WT were seeded in DMEM containing 5% calf serum on 60-mm-diameter plates at a density of 10 4 cells per plate. After cells were allowed to attach overnight, the medium was replaced with DMEM containing 0.5, 2, or 10% calf serum and incubated for 6 days. Cells were trypsinized and counted in a hemacytometer. Data are averaged from results with two clones of each cell type except F111. of the molecular and cell biological aspects of mutant virus infections in culture should enable a better understanding of the processes that accompany neoplastic transformation of a variety of different cell types in mice.
